A charity says it is "disappointed" over a decision not to provide a life-extending breast cancer drug on the NHS. The National Institute for Health and Care Excellence concluded it could not be predicted how long pertuzumab extended people's lives.
Mia Rosenblatt, head of policy and campaigns at Breast Cancer Campaign hopes NICE's decision on pertuzumab can be reversed following the consultation process:
The Democratic presidential candidate may also have shown his cards on his choice of running mate.
The US president also shared a post on Twitter accusing Dr Anthony Fauci of misleading the public over hydroxychloroquine.
Fears over an impending second wave of coronavirus dominates Wednesday’s front pages.